Resiliency in Total Joint Arthroplasty

Study Overview
=================
Brief Summary
-----------------
The investigators primary objective is to determine how does participation in StreaMD affect patient reported outcomes after Total Hip Arthroplasty (THA) or Total Knee Arthroplasty (TKA)?

Detailed Description
-----------------
Osteoarthritis is a leading cause of disability in the US. By conservative estimates, about 54 million adults in the US have doctor-diagnosed arthritis. The number of people expected to have arthritis by the year 2040 is more than 78 million. Total joint arthroplasty is considered the treatment of choice for end-stage osteoarthritis. Currently, more than 1 million hip and knee replacements are performed each year in the US. By 2030, primary THR is projected to grow 171% and primary TKR is projected to grow by up to 189%, for a projected 635,000 and 1.28 million procedures, respectively. The incidence of pre-operative psychological distress in this group of patients is reported between 30% and 60% and preoperative psychological distress is associated with poorer pain and functional outcomes after surgery. Resilience, characterized by an ability to bounce back or recover from stress, is increasingly recognized as a psychometric property affecting many outcomes' domains including outcomes after TJA. Better resilience could improve patients overall satisfaction with the procedure.

Official Title
-----------------
Resiliency in Total Joint Arthroplasty

Conditions
-----------------
Osteoarthritis

Intervention / Treatment
-----------------
* Other: StreaMD


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: All patients aged 18 and older who are receiving a total hip or knee replacement. Exclusion Criteria: Patients enrolled in the MyMobility study Patients who do not have cell phones with text messaging capability Non-English speaking patients

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 90 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Other
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| No Intervention: Control<br>No other non-standard of care activities will be performed | |
| Experimental: Intervention<br>Will be signed up for the automated text messaging program (StreaMD) | Other: StreaMD<br>* Patients who are randomized to the intervention arm will be signed up for the automated text messaging program. Patients will receive automated text messages related to their surgery during the study period and can also ask questions through the text messages program, where automated messages will be sent based on the questions asked.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patient Reported Outcome Score (PROMIS) following THA or TKA | Patient reported outcome will consist of the Patient-Reported Outcomes Measurement Information System (PROMIS) | Follow Up Visits up to 2-Years | 
| Patient Reported Outcome Score (HOOS Jr.) following THA or TKA | Patient reported outcome will consist of the hip disability and osteoarthritis outcome score (HOOS Jr.) | Follow Up Visits up to 2-Years | 
| Patient Reported Outcome Score (KOOS Jr.) following THA or TKA | Patient reported outcome will consist of the knee injury and osteoarthritis outcome score (KOOS Jr.) | Follow Up Visits up to 2-Years | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Total Hip Arthroplasty, Total Knee Arthroplasty, Patient Reported Outcomes, Resilience